Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Jun 30, 2025 | (FY)Jun 30, 2024 | (FY)Jun 30, 2023 | (FY)Jun 30, 2022 | (FY)Jun 30, 2021 | |
|---|---|---|---|---|---|
| Total revenue | |||||
| Cost of revenue | |||||
| Gross profit | |||||
| Operating expense | -7.31%1.44M | 25.63%1.56M | -8.83%1.24M | 15.95%1.36M | 1.17M |
| Selling and administrative expenses | 11.29%1.24M | 2.30%1.11M | 30.53%1.09M | 49.18%833.64K | --558.8K |
| -General and administrative expense | 11.29%1.24M | 2.30%1.11M | 30.53%1.09M | 49.18%833.64K | --558.8K |
| Depreciation amortization depletion | -57.05%22.85K | -6.29%53.19K | 57.88%56.76K | 3,782.61%35.95K | --926 |
| -Depreciation and amortization | -57.05%22.85K | -6.29%53.19K | 57.88%56.76K | 3,782.61%35.95K | --926 |
| Other operating expenses | -53.50%181.84K | 312.58%391.05K | -80.66%94.78K | -20.04%490.17K | --612.98K |
| Operating profit | 7.31%-1.44M | -25.63%-1.56M | 8.83%-1.24M | -15.95%-1.36M | -1.17M |
| Net non-operating interest income (expenses) | 119.46%37.16K | 544.25%16.93K | 186.36%2.63K | -594.80%-3.04K | 615 |
| Non-operating interest income | 76.64%43.21K | 175.27%24.46K | 2,105.21%8.89K | -35.10%403 | --621 |
| Non-operating interest expense | -79.53%1K | -21.73%4.9K | 81.63%6.26K | 57,333.33%3.45K | --6 |
| Total other finance cost | 91.83%5.05K | --2.63K | ---- | ---- | ---- |
| Other net income (expenses) | 2,107.47%146.25K | -61.73%6.63K | -72.13%17.31K | 62.1K | |
| Other non-operating income (expenses) | 2,107.47%146.25K | -61.73%6.63K | -72.13%17.31K | --62.1K | ---- |
| Income before tax | 17.85%-1.26M | -25.75%-1.53M | 6.22%-1.22M | -10.97%-1.3M | -1.17M |
| Income tax | 0 | 0 | 0 | 0 | 0 |
| Earnings from equity interest net of tax | |||||
| Net income | 17.85%-1.26M | -25.75%-1.53M | 6.22%-1.22M | -10.97%-1.3M | -1.17M |
| Net income continuous operations | 17.85%-1.26M | -25.75%-1.53M | 6.22%-1.22M | -10.97%-1.3M | ---1.17M |
| Noncontrolling interests | |||||
| Net income attributable to the company | 17.85%-1.26M | -25.75%-1.53M | 6.22%-1.22M | -10.97%-1.3M | -1.17M |
| Preferred stock dividends | |||||
| Other under preferred stock dividend | |||||
| Net income attributable to common stockholders | 17.85%-1.26M | -25.75%-1.53M | 6.22%-1.22M | -10.97%-1.3M | -1.17M |
| Diluted earnings per share | 51.69%-0.0043 | 53.16%-0.0089 | 24.90%-0.019 | -13.45%-0.0253 | -0.0223 |
| Basic earnings per share | 51.69%-0.0043 | 53.16%-0.0089 | 24.90%-0.019 | -13.45%-0.0253 | -0.0223 |
| Dividend per share | |||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |